414 related articles for article (PubMed ID: 25538227)
1. Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia.
Iriyama T; Sun K; Parchim NF; Li J; Zhao C; Song A; Hart LA; Blackwell SC; Sibai BM; Chan LN; Chan TS; Hicks MJ; Blackburn MR; Kellems RE; Xia Y
Circulation; 2015 Feb; 131(8):730-41. PubMed ID: 25538227
[TBL] [Abstract][Full Text] [Related]
2. Elevated Adenosine Induces Placental DNA Hypomethylation Independent of A2B Receptor Signaling in Preeclampsia.
Huang A; Wu H; Iriyama T; Zhang Y; Sun K; Song A; Liu H; Peng Z; Tang L; Lee M; Huang Y; Ni X; Kellems RE; Xia Y
Hypertension; 2017 Jul; 70(1):209-218. PubMed ID: 28507174
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-independent upregulation of placental hypoxia inducible factor-1α gene expression contributes to the pathogenesis of preeclampsia.
Iriyama T; Wang W; Parchim NF; Song A; Blackwell SC; Sibai BM; Kellems RE; Xia Y
Hypertension; 2015 Jun; 65(6):1307-15. PubMed ID: 25847948
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal upregulation of hypoxia-inducible factor-1α and persistently enhanced placental adenosine signaling contribute to the pathogenesis of preeclampsia.
Iriyama T; Wang W; Parchim NF; Sayama S; Kumasawa K; Nagamatsu T; Song A; Xia Y; Kellems RE
FASEB J; 2020 Mar; 34(3):4041-4054. PubMed ID: 31930569
[TBL] [Abstract][Full Text] [Related]
5. Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension.
Zhang W; Zhang Y; Wang W; Dai Y; Ning C; Luo R; Sun K; Glover L; Grenz A; Sun H; Tao L; Zhang W; Colgan SP; Blackburn MR; Eltzschig HK; Kellems RE; Xia Y
Circ Res; 2013 May; 112(11):1466-78. PubMed ID: 23584256
[TBL] [Abstract][Full Text] [Related]
6. Excess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia.
Wang W; Parchim NF; Iriyama T; Luo R; Zhao C; Liu C; Irani RA; Zhang W; Ning C; Zhang Y; Blackwell SC; Chen L; Tao L; Hicks MJ; Kellems RE; Xia Y
Hypertension; 2014 Mar; 63(3):595-606. PubMed ID: 24324043
[TBL] [Abstract][Full Text] [Related]
7. Response to Letter Regarding Article, "Elevated Placental Adenosine Signaling Contributes to the Pathogenesis of Preeclampsia".
Iriyama T; Sun K; Parchim NF; Li J; Zhao C; Song A; Hart LA; Blackwell SC; Sibai BM; Chan LN; Chan TS; Hicks JM; Blackburn MR; Kellems RE; Xia Y
Circulation; 2015 Nov; 132(18):e222-3. PubMed ID: 26527698
[No Abstract] [Full Text] [Related]
8. Letter by Escudero et al Regarding Article, "Elevated Placental Adenosine Signaling Contributes to the Pathogenesis of Preeclampsia".
Escudero C; Myatt L; Roberts JM
Circulation; 2015 Nov; 132(18):e221. PubMed ID: 26527697
[No Abstract] [Full Text] [Related]
9. A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice.
Lai Z; Kalkunte S; Sharma S
Hypertension; 2011 Mar; 57(3):505-14. PubMed ID: 21263114
[TBL] [Abstract][Full Text] [Related]
10. Soluble endoglin contributes to the pathogenesis of preeclampsia.
Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA
Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767
[TBL] [Abstract][Full Text] [Related]
11. A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium.
Escudero C; Sobrevia L
Placenta; 2008 Jun; 29(6):469-83. PubMed ID: 18359514
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia.
Wang W; Irani RA; Zhang Y; Ramin SM; Blackwell SC; Tao L; Kellems RE; Xia Y
Hypertension; 2012 Sep; 60(3):712-21. PubMed ID: 22868393
[TBL] [Abstract][Full Text] [Related]
13. Neurokinin 3 receptor and phosphocholine transferase: missing factors for pathogenesis of C-reactive protein in preeclampsia.
Parchim NF; Wang W; Iriyama T; Ashimi OA; Siddiqui AH; Blackwell S; Sibai B; Kellems RE; Xia Y
Hypertension; 2015 Feb; 65(2):430-9. PubMed ID: 25452470
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of complement activation prevents features of preeclampsia in mice.
Qing X; Redecha PB; Burmeister MA; Tomlinson S; D'Agati VD; Davisson RL; Salmon JE
Kidney Int; 2011 Feb; 79(3):331-9. PubMed ID: 20944547
[TBL] [Abstract][Full Text] [Related]
16. Role of complement component C1q in the onset of preeclampsia in mice.
Singh J; Ahmed A; Girardi G
Hypertension; 2011 Oct; 58(4):716-24. PubMed ID: 21859968
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms of Preeclampsia.
Hod T; Cerdeira AS; Karumanchi SA
Cold Spring Harb Perspect Med; 2015 Aug; 5(10):. PubMed ID: 26292986
[TBL] [Abstract][Full Text] [Related]
18. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1.
Makris A; Thornton C; Thompson J; Thomson S; Martin R; Ogle R; Waugh R; McKenzie P; Kirwan P; Hennessy A
Kidney Int; 2007 May; 71(10):977-84. PubMed ID: 17377512
[TBL] [Abstract][Full Text] [Related]
19. Loss of Thrombomodulin in Placental Dysfunction in Preeclampsia.
Turner RJ; Bloemenkamp KW; Bruijn JA; Baelde HJ
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):728-35. PubMed ID: 26891741
[TBL] [Abstract][Full Text] [Related]
20. Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia.
Hoffmann DS; Weydert CJ; Lazartigues E; Kutschke WJ; Kienzle MF; Leach JE; Sharma JA; Sharma RV; Davisson RL
Hypertension; 2008 Apr; 51(4):1058-65. PubMed ID: 18259014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
